Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Camidge to Thoracic Neoplasms

This is a "connection" page, showing publications David Camidge has written about Thoracic Neoplasms.

 
Connection Strength
 
 
 
2.668
 
  1. Gerber DE, Wynters CR, Prasad T, Schnel RK, Zhang S, Stinchcombe TE, Villaruz LC, Bauml JM, Iams WT, Patil T, Liu SV, Horn L, Hudak JM, Camidge DR. Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials. Clin Cancer Res. 2025 Mar 17; 31(6):1103-1108.
    View in: PubMed
    Score: 0.938
  2. Camidge DR. A rational approach to the development of drug combinations in thoracic oncology. Clin Adv Hematol Oncol. 2019 Aug; 17(8):430-432.
    View in: PubMed
    Score: 0.635
  3. Pacheco JM, Camidge DR. Antibody drug conjugates in thoracic malignancies. Lung Cancer. 2018 10; 124:260-269.
    View in: PubMed
    Score: 0.591
  4. Whittington MD, Atherly AJ, Bocsi GT, Camidge DR. A Primer on Health Economic Evaluations in Thoracic Oncology. J Thorac Oncol. 2016 08; 11(8):1224-1232.
    View in: PubMed
    Score: 0.505
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)